ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

Also in This 8-page Issue: In Overhaul of Ethics Rules, NIH Bans Employees From Consulting for and Owning Stock in Biomedical Companies.

February 4, 2005

To Become Effective Lobbyists, Scientists Seek Alliances With Patient Advocates

March 31, 1995

Obama Picks Hamburg for FDA Commissioner

March 20, 2009

Letter In Response To Hadley; RFA Available

July 7, 1995

Radium Society To Meet In L.A.

March 2, 1979

Feds Should Lead Quality Improvement In Government Health Programs, IOM Report Says

November 8, 2002